This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

DVC1-0101

ID Pharma Co., Ltd.

Drug Names(s): SeV-FGF2 gene therapy, SeV-1-0101

Description: DVC1-0101 is a recombinant Sendai virus (SeV) carrying the fibroblast growth factor-2 (FGF2) gene.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug